CONCHO RESOURCES INC. [ ] Shares of Common Stock Underwriting Agreement
Exhibit 1.1
[ ] Shares of Common Stock
[ ], 2007
X.X. Xxxxxx Securities Inc.
Banc of America Securities LLC
Banc of America Securities LLC
As Representatives of the
several Underwriters listed
in Schedule 1 hereto
several Underwriters listed
in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
Concho Resources Inc., a Delaware corporation (“the Company”) proposes to issue and sell to
the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting
as representatives (collectively, the “Representatives”), an aggregate of [ ] shares of
Common Stock, par value $0.001 per share, of the Company, and Chase Oil Corporation and Caza Energy
LLC (together, the “Chase Stockholders”) and certain other stockholders (collectively, the
“Non-Chase Stockholders,” and together with Chase Stockholders, the “Selling Stockholders”) of the
Company named in Schedules 3 and 4 hereto propose to sell to the Underwriters an aggregate of [
] shares of Common Stock of the Company. At the option of the Underwriters, the Chase
Stockholders propose to sell up to an additional [ ] shares of Common Stock of the Company.
The aggregate of [ ] shares which may be sold by the Company and the Selling Stockholders
is herein called the “Underwritten Shares,” and the aggregate of [ ] additional shares to
be sold by the Chase Stockholders is herein called the “Option Shares.” The Underwritten Shares
and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the
Company to be outstanding after giving effect to the sale of the Shares are herein referred to as
the “Stock”.
The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Underwritten Shares to be sold by the Company, the Selling Stockholders
hereby confirm their agreement with the several Underwriters concerning the purchase and sale of
the Underwritten Shares to be sold by the Selling Stockholders, and the Chase Stockholders hereby
confirm their agreement with the several Underwriters concerning the purchase and sale of the
Option Shares which may be sold by the Chase Stockholders as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and
Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the “Securities Act”), a registration
statement on Form S-1(File No. 333-142315) including a prospectus, relating to the Shares. Such
registration statement, as amended at the time it becomes effective, including the information, if
any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the
registration statement at the time of its effectiveness (“Rule 430 Information”), is referred to
herein as the “Registration Statement”; and as used herein, the term “Preliminary Prospectus” means
each prospectus included in such registration statement (and any amendments thereto) before it
becomes effective, any prospectus filed with the Commission pursuant to Rule 424(a) under the
Securities Act and the prospectus included in the Registration
Statement at the time of its effectiveness that omits Rule 430 Information, and the term
“Prospectus” means the prospectus in the form first used (or made available upon the request of
purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales
of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule
462(b) under the Securities Act (the “Rule 462 Registration Statement”), then any reference herein
to the term “Registration Statement” shall be deemed to include such Rule 462 Registration
Statement. Capitalized terms used but not defined herein shall have the meanings given to such
terms in the Registration Statement and the Prospectus.
At or prior to the time when sales of the Shares were first made (the “Time of Sale”), the
Company had prepared the following information (collectively with the pricing information set forth
on Annex C hereto, the “Time of Sale Information”): a Preliminary Prospectus dated [
], 2007, and each “free-writing prospectus” (as defined pursuant to Rule 405 under the Securities
Act) listed on Annex C hereto.
2. Purchase of the Shares by the Underwriters.
(a) The Company and each Selling Stockholder agrees, severally and not jointly, to sell the
Underwritten Shares to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company and from each Selling Stockholder at a price per share of $[ ] (the “Purchase Price”)
the number of Underwritten Shares (to be adjusted by you so as to eliminate fractional shares)
determined by multiplying the aggregate number of Underwritten Shares to be sold by the Company or
such Selling Stockholder, as the case may be, as set forth opposite their respective names in
Schedule 2 hereto by a fraction, the numerator of which is the aggregate number of Underwritten
Shares to be purchased by such Underwriter as set forth opposite the name of such Underwriter in
Schedule 1 hereto and the denominator of which is the aggregate number of Underwritten Shares to be
purchased by all the Underwriters from the Company and all the Selling Stockholders hereunder.
In addition, the Chase Stockholders, as and to the extent indicated in Schedule 2 hereto,
agree, severally and not jointly, to sell the Option Shares to the several Underwriters and the
Underwriters shall have the option to purchase at their election all or any portion of the Option
Shares at the Purchase Price. The Underwriters, on the basis of the representations and warranties
and agreements herein contained and subject to the conditions set forth herein, shall have the
option to purchase, severally and not jointly, from the Chase Stockholders all or any portion of
the Option Shares at the Purchase Price. If any Option Shares are to be purchased, the number of
Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears
the same ratio to the aggregate number of Option Shares being purchased as the number of
Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (or such
number increased as set forth in Section 12 hereof) bears to the aggregate number of Underwritten
Shares being purchased from the Company and the Selling Stockholders by the several Underwriters,
subject, however, to such adjustments to eliminate any fractional Shares as the Representatives in
their sole discretion shall make. Any such election to purchase Option Shares shall be made
accordance with the percentages of the total amount of Option Shares to be sold by each Chase
Stockholder as set forth in Schedule 2 hereto.
The Underwriters may exercise the option to purchase the Option Shares at any time in whole,
or from time to time in part, on or before the thirtieth day following the date of this Agreement,
by written notice from the Representatives to the Company and the Chase Stockholders. Such notice
shall set forth the aggregate number of Option Shares as to which the option is being exercised and
the date and time when the Option Shares are to be delivered and paid for which may be the same
date and time as the
-2-
Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later
than the tenth full business day (as hereinafter defined) after the date of such notice (unless
such time and date are postponed in accordance with the provisions of Section 12 hereof). Any such
notice shall be given at least two Business Days prior to the date and time of delivery specified
therein.
(b) The Company and the Selling Stockholders understand that the Underwriters intend to make a
public offering of the Shares as soon after the effectiveness of this Agreement as in the judgment
of the Representatives is advisable, and initially to offer the Shares on the terms set forth in
the Prospectus. The Company and the Selling Stockholders acknowledge and agree that the
Underwriters may offer and sell Shares to or through any affiliate of an Underwriter and that any
such affiliate may offer and sell Shares purchased by it to or through any Underwriter.
(c) Payment for the Shares shall be made by wire transfer in immediately available funds to
the accounts specified by the Company and the Selling Stockholders to the Representatives in the
case of the Underwritten Shares, at the offices of Xxxxxx Xxxxxx & Xxxxxxx llp, 00 Xxxx
Xxxxxx, Xxx Xxxx, Xxx Xxxx, 00000 at 10:00 A.M. New York City time on [ ], 2007,
or at such other time or place on the same or such other date, not later than the fifth business
day thereafter, as the Representatives, the Company and the Selling Stockholders may agree upon in
writing or, in the case of the Option Shares, on the date and at the time and place specified by
the Representatives in the written notice of the Underwriters’ election to purchase such Option
Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the
“Closing Date” and the time and date for such payment for the Option Shares, if other than the
Closing Date, is herein referred to as the “Additional Closing Date”.
Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as
the case may be, shall be made against delivery through the facilities of the Depository Trust
Company (“DTC”) to the Representatives for the respective accounts of the several Underwriters of
the Shares to be purchased on such date in definitive form registered in such names and in such
denominations as the Representatives shall request in writing not later than two full business days
prior to the Closing Date or the Additional Closing Date, as the case may be, with any transfer
taxes payable in connection with the sale of the Shares duly paid by the Company or the Selling
Stockholders. Any certificates for the Shares will be made available for inspection and packaging
by the Representatives at the office of DTC or its designated custodian not later than 1:00 P.M.,
New York City time, on the business day prior to the Closing Date or the Additional Closing Date,
as the case may be.
(d) The Company and the Selling Stockholders acknowledge and agree that the Underwriters are
acting solely in the capacity of an arm’s length contractual counterparty to the Company and the
Selling Stockholders with respect to the offering of Shares contemplated hereby (including in
connection with determining the terms of the offering) and not as a financial advisor or a
fiduciary to, or an agent of, the Company, the Selling Stockholders or any other person.
Additionally, neither the Representatives nor any other Underwriter is advising the Company, the
Selling Stockholders or any other person as to any legal, tax, investment, accounting or
regulatory matters in any jurisdiction. The Company and the Selling Stockholders shall consult
with their own advisors concerning such matters and shall be responsible for making their own
independent investigation and appraisal of the transactions contemplated hereby, and the
Underwriters shall have no responsibility or liability to the Company or the Selling Stockholders
with respect thereto. Any review by the Underwriters of the Company or the Selling Stockholders,
the transactions contemplated hereby or other matters relating to such transactions will be
performed solely for the benefit of the Underwriters and shall not be on behalf of the Company or
the Selling Stockholders.
3. Representations and Warranties of the Company. The Company represents and warrants
to each Underwriter and each Selling Stockholder that:
-3-
(a) Preliminary Prospectus. No order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, complied in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; provided that the Company makes no representation and
warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in any Preliminary Prospectus.
(b) Time of Sale Information. The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation and warranty with respect to
any statements or omissions made in reliance upon and in conformity with information relating to
any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in such Time of Sale Information. No statement of material fact included in the
Prospectus has been omitted from the Time of Sale Information and no statement of material fact
included in the Time of Sale Information that is required to be included in the Prospectus has been
omitted therefrom.
(c) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the Prospectus,
the Company (including its agents and representatives) has not made, used, prepared, authorized,
approved or referred to and will not prepare, make, use, authorize, approve or refer to any
“written communication” (as defined in Rule 405 under the Securities Act) that constitutes an offer
to sell or solicitation of an offer to buy the Shares (each such communication by the Company or
its agents and representatives (other than a communication referred to in clause (i) below) an
“Issuer Free Writing Prospectus”) other than (i) any document not constituting a prospectus
pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii)
the documents listed on Annex B hereto and other written communications approved in writing in
advance by the Representatives. Each such Issuer Free Writing Prospectus complied in all material
respects with the Securities Act, has been filed in accordance with the Securities Act (to the
extent required thereby) and, when taken together with the Preliminary Prospectus accompanying, or
delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and at the Closing
Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
provided that the Company makes no representation and warranty with respect to any
statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in
conformity with information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use in any Issuer Free Writing Prospectus.
(d) Registration Statement and Prospectus. The Registration Statement has been declared
effective by the Commission. No order suspending the effectiveness of the Registration Statement
has been issued by the Commission and no proceeding for that purpose or pursuant to Section 8A of
the Securities Act against the Company or related to the offering has been initiated or threatened
by the Commission; as of the applicable effective date of the Registration Statement and any
amendment thereto, the Registration Statement complied and will comply in all material respects
with the Securities Act, and did not and will not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein not misleading; and as of the date of the Prospectus and any amendment or
supplement thereto and as of the Closing Date and as of the
-4-
Additional Closing Date, as the case may be, the Prospectus will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; provided that the Company makes no representation and warranty with respect
to any statements or omissions made in reliance upon and in conformity with information relating to
any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in the Registration Statement and the Prospectus and any amendment or supplement
thereto.
(e) Financial Statements. (i) The financial statements and the related notes thereto of the
Company and its consolidated subsidiaries included in the Registration Statement, the Time of Sale
Information and the Prospectus comply in all material respects with the applicable requirements of
the Securities Act and the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission thereunder (collectively, the “Exchange Act”), as applicable, except
to the extent relief therefrom has been granted in writing by the Staff of the SEC and present
fairly in all material respects the financial position of the Company and its subsidiaries as of
the dates indicated and the results of their operations and the changes in their cash flows for the
periods specified; such financial statements have been prepared in conformity with generally
accepted accounting principles applied on a consistent basis throughout the periods covered
thereby, and the supporting schedules included in the Registration Statement present fairly in all
material respects the information required to be stated therein; the other financial information
included in the Registration Statement, the Time of Sale Information and the Prospectus has been
derived from the accounting records of the Company and its subsidiaries and presents fairly in all
material respects the information shown thereby; and the pro forma financial information and the
related notes thereto included in the Registration Statement, the Time of Sale Information and the
Prospectus have been prepared in all material respects consistently with the applicable
requirements of the Securities Act and the Exchange Act, as applicable, and give effect to
assumptions made on a reasonable basis as set forth in the Registration Statement, the Time of Sale
Information and the Prospectus;
(ii) The statements of revenue and direct operating expenses and the related notes thereto of
the Xxxx Properties included in the Registration Statement, the Time of Sale Information and the
Prospectus comply in all material respects with the applicable requirements of the Securities Act
and the Securities Exchange Act, as applicable, and present fairly in all material respects the
revenues and direct operating expenses of the Xxxx Properties for the periods specified; such
financial statements have been prepared in conformity with generally accepted accounting principles
applied on a consistent basis throughout the periods covered thereby; the other financial
information included in the Registration Statement, the Time of Sale Information and the Prospectus
of the Xxxx Properties has been derived from the accounting records of the Xxxx Properties and
presents fairly in all material respects the information shown thereby; and
(iii) The financial statements and the related notes thereto of the Chase Group Properties
included in the Registration Statement, the Time of Sale Information and the Prospectus (and as
defined therein) comply in all material respects with the applicable requirements of the Securities
Act and the Exchange Act, as applicable, and present fairly in all material respects the financial
position of the Chase Group Properties as of the dates indicated and the results of their
operations and the changes in their cash flows for the periods specified; such financial statements
have been prepared in conformity with generally accepted accounting principles applied on a
consistent basis throughout the periods covered thereby, the other financial information included
in the Registration Statement, the Time of Sale Information and the Prospectus has been derived
from the accounting records of the Chase Group Properties and presents fairly in all material
respects the information shown thereby.
-5-
(f) No Material Adverse Change. Since the date of the most recent financial statements of the
Company included in the Registration Statement, the Time of Sale Information and the Prospectus,
except in each case as otherwise disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, (i) there has not been any change in the capital stock or long-term
debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind
declared, set aside for payment, paid or made by the Company on any class of capital stock, or any
material adverse change, or any development involving a prospective material adverse change, in or
affecting the business, properties, management, financial position, stockholders’ equity, results
of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) neither the
Company nor any of its subsidiaries has entered into any transaction or agreement that is material
to the Company and its subsidiaries taken as a whole or incurred any liability or obligation,
direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and
(iii) neither the Company nor any of its subsidiaries has sustained any material loss or
interference with its business from fire, explosion, flood or other calamity, whether or not
covered by insurance, or from any labor disturbance or dispute or any action, order or decree of
any court or arbitrator or governmental or regulatory authority, except in each case as otherwise
disclosed in the Registration Statement, the Time of Sale Information and the Prospectus.
(g) Organization and Good Standing. The Company and each of its subsidiaries have been duly
organized and are validly existing and in good standing under the laws of their respective
jurisdictions of organization, are duly qualified to do business and are in good standing in each
jurisdiction in which their respective ownership or lease of property or the conduct of their
respective businesses requires such qualification, and have all power and authority necessary to
own or hold their respective properties and to conduct the businesses in which they are engaged,
except where the failure to be so qualified or have such power or authority would not, individually
or in the aggregate, have a material adverse effect on the business, properties, management,
financial position, stockholders’ equity, results of operations, cash flows or prospects of the
Company and its subsidiaries taken as a whole (a “Material Adverse Effect”). The Company does not
own or control, directly or indirectly, any corporation, association or other entity other than the
subsidiaries listed in Exhibit 21 to the Registration Statement.
(h) Capitalization. The Company has authorized capital stock as set forth in the Registration
Statement, the Time of Sale Information and the Prospectus under the heading “Capitalization”; all
the outstanding shares of capital stock of the Company have been duly and validly authorized and
issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar
rights; except as described in or expressly contemplated by the Time of Sale Information and the
Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights),
warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of
capital stock or other equity interest in the Company or any of its subsidiaries, or any contract,
commitment, agreement, understanding or arrangement of any kind relating to the issuance of any
capital stock of the Company or any such subsidiary, any such convertible or exchangeable
securities or any such rights, warrants or options; the capital stock of the Company conforms in
all material respects to the description thereof contained in the Registration Statement, the Time
of Sale Information and the Prospectus; and all the outstanding shares of capital stock or other
equity interests of each subsidiary of the Company have been duly and validly authorized and
issued, are fully paid and non-assessable (except as otherwise described in the Registration
Statement, the Time of Sale Information and the Prospectus) and are owned directly or indirectly by
the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on
voting or transfer or any other claim of any third party, other than those arising under the
Company’s Credit Agreement dated February 24, 2006 and Second Lien Credit Agreement dated March 27,
2007.
(i) Due Authorization. The Company has full corporate, power and authority to execute and
deliver this Agreement and to perform its obligations hereunder; and all corporate action required
to be
-6-
taken for the due and proper authorization, execution and delivery by it of this Agreement and
the consummation by it of the transactions contemplated hereby has been duly and validly taken.
(j) Underwriting Agreement. This Agreement has been duly authorized, executed and delivered
by the Company.
(k) The Shares. The Shares to be issued and sold by the Company hereunder have been duly
authorized by the Company and, when issued and delivered and paid for as provided herein, will be
duly and validly issued and will be fully paid and nonassessable and will conform to the
descriptions thereof in the Registration Statement, the Time of Sale Information and the
Prospectus; and the issuance of the Shares to be sold by the Company hereunder is not subject to
any preemptive or similar rights.
(l) No Violation or Default. Neither the Company nor any of its subsidiaries is (i) in
violation of its charter or by-laws or similar organizational documents; (ii) in default, and no
event has occurred that, with notice or lapse of time or both, would constitute such a default, in
the due performance or observance of any term, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or
any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or
to which any of the property or assets of the Company or any of its subsidiaries is subject; or
(iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or
arbitrator or governmental or regulatory authority, except, in the case of clauses (ii) and (iii)
above, for any such default or violation that would not, individually or in the aggregate, have a
Material Adverse Effect.
(m) No Conflicts. The execution, delivery and performance by the Company of this Agreement,
the issuance and sale of the Shares and the consummation of the transactions contemplated by this
Agreement will not (i) conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company or any of its subsidiaries
pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which the Company or any of its subsidiaries is a party or by which the Company or
any of its subsidiaries is bound or to which any of the property or assets of the Company or any of
its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or
by-laws or similar organizational documents of the Company or any of its subsidiaries or (iii)
result in the violation of any law or statute or any judgment, order, rule or regulation of any
court or arbitrator or governmental or regulatory authority.
(n) No Consents Required. No consent, approval, authorization, order, registration or
qualification of or with any court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company of this Agreement, the issuance
and sale of the Shares and the consummation of the transactions contemplated by this Agreement,
except for the registration of the Shares under the Securities Act and such consents, approvals,
authorizations, orders and registrations or qualifications as may be required under applicable
state securities laws in connection with the purchase and distribution of the Shares by the
Underwriters and any consent, approval, authorization, order, registration or qualification that
either has been, or prior to the Closing Date will have been, obtained or made, or which if not
obtained or made, would not, individually or in the aggregate, have a Material Adverse Effect and
would not adversely affect the Company’s ability to fulfill its obligations under this Agreement.
(o) Legal Proceedings. Except as described in the Registration Statement, the Time of Sale
Information and the Prospectus, there are no legal, governmental or regulatory investigations,
actions, suits or proceedings pending to which the Company or any of its subsidiaries is or may be
a party or to which any property of the Company or any of its subsidiaries is or may be the subject
that, individually or
-7-
in the aggregate, if determined adversely to the Company or any of its subsidiaries, could
reasonably be expected to have a Material Adverse Effect or materially and adversely affect the
ability of the Company to perform its obligations under this Agreement; to the knowledge of the
Company, no such investigations, actions, suits or proceedings are threatened or contemplated by
any governmental or regulatory authority or others; and (i) there are no current or pending legal,
governmental or regulatory actions, suits or proceedings that are required under the Securities Act
to be described in the Registration Statement that are not so described in the Registration
Statement, the Time of Sale Information and the Prospectus and (ii) there are no statutes,
regulations or contracts or other documents that are required under the Securities Act to be filed
as exhibits to the Registration Statement or described in the Registration Statement or the
Prospectus that are not so filed as exhibits to the Registration Statement or described in the
Registration Statement, the Time of Sale Information and the Prospectus.
(p) Independent Accountants. Xxxxx Xxxxxxxx LLP, who has certified certain financial
statements of the Company and its subsidiaries, is an independent registered public accounting firm
with respect to the Company and its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as
required by the Securities Act.
(q) Title to Real and Personal Property. The Company and its subsidiaries have good and
marketable title to all real and other property they own, in each case free and clear of all liens,
encumbrances and defects except those (i) described in the Registration Statement, the Time of Sale
Information and the Prospectus or (ii) that could not reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect. Except as described in the Registration
Statement, the Time of Sale Information and the Prospectus, all items of real and other property
leased by the Company and its subsidiaries are leased under valid and enforceable leases, except as
could not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect.
(r) Title to Intellectual Property. The Company and its subsidiaries own or possess adequate
rights to use any and all material patents, patent applications, trademarks, service marks, trade
names, trademark registrations, service xxxx registrations, copyrights, licenses and know-how
(including trade secrets and other unpatented and/or unpatentable proprietary or confidential
information, systems or procedures) necessary for the conduct of their respective businesses; and
the conduct of their respective businesses will not conflict in any material respect with any such
rights of others, and the Company and its subsidiaries have not received any notice of any claim of
infringement or conflict with any such rights of others.
(s) No Undisclosed Relationships. No relationship, direct or indirect, exists between or
among the Company or any of its subsidiaries, on the one hand, and the directors, officers,
stockholders, customers or suppliers of the Company or any of its subsidiaries, on the other, that
is required by the Securities Act to be described in the Registration Statement and the Prospectus
and that is not so described in such documents and in the Time of Sale Information.
(t) Investment Company Act. The Company is not and, after giving effect to the offering and
sale of the Shares and the application of the proceeds thereof as described in the Registration
Statement, the Time of Sale Information and the Prospectus, will not be required to register as an
“investment company” or an entity “controlled” by an “investment company” within the meaning of the
Investment Company Act of 1940, as amended, and the rules and regulations of the Commission
thereunder (collectively, “Investment Company Act”).
(u) Taxes. The Company and its subsidiaries have paid all federal, state, local and foreign
taxes and filed all tax returns required to be paid or filed through the date hereof; and except as
otherwise
-8-
disclosed in the Registration Statement, the Time of Sale Information and the Prospectus or as
would not, individually or in the aggregate, have a Material Adverse Effect, there is no tax
deficiency that has been, or could reasonably be expected to be, asserted against the Company or
any of its subsidiaries or any of their respective properties or assets.
(v) Licenses and Permits. The Company and its subsidiaries possess all licenses,
certificates, permits and other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or the
conduct of their respective businesses as described in the Registration Statement, the Time of Sale
Information and the Prospectus, except where the failure to possess or make the same would not,
individually or in the aggregate, have a Material Adverse Effect; and except as described in the
Registration Statement, the Time of Sale Information and the Prospectus or as would not,
individually or in the aggregate, have a Material Adverse Effect, neither the Company nor any of
its subsidiaries has received notice of any revocation or modification of any such license,
certificate, permit or authorization or has any reason to believe that any such license,
certificate, permit or authorization will not be renewed in the ordinary course.
(w) No Labor Disputes. No labor disturbance by or dispute with employees of the Company or
any of its subsidiaries exists or, to the knowledge of the Company, is contemplated or threatened
and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the
employees of any of its or its subsidiaries’ principal suppliers, contractors or customers, except
as would not have a Material Adverse Effect.
(x) Compliance With Environmental Laws. (i) The Company and its subsidiaries (x) are in
compliance with any and all applicable federal, state, local and foreign laws, rules, regulations,
requirements, decisions and orders relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively,
“Environmental Laws”); (y) have received and are in compliance with all permits, licenses,
certificates or other authorizations or approvals required of them under applicable Environmental
Laws to conduct their respective businesses; and (z) except as described in the Registration
Statement, the Time of Sale Information and the Prospectus, have not received notice of any actual
or potential liability for the investigation or remediation of any disposal or release of hazardous
or toxic substances or wastes, pollutants or contaminants, and (ii) there are no costs or
liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries,
except for any such failure to comply, or failure to receive required permits, licenses or
approvals, or cost or liability, as would not, individually or in the aggregate, have a Material
Adverse Effect.
(y) Compliance With ERISA. Each employee benefit plan, within the meaning of Section 3(3) of
the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that is maintained,
administered or contributed to by the Company or any of its affiliates for employees or former
employees of the Company and its affiliates has been maintained in compliance in all material
respects with its terms and the requirements of any applicable statutes, orders, rules and
regulations, including, but not limited to, ERISA and the Internal Revenue Code of 1986, as amended
(the “Code”); no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975
of the Code, has occurred with respect to any such plan excluding transactions effected pursuant to
a statutory or administrative exemption; and transactions which, individually or in the aggregate,
would not have a Material Adverse Effect, and no such plan is subject to the funding rules of
Section 412 of the Code or Section 302 of ERISA.
(z) Disclosure Controls. The Company and its subsidiaries maintain an effective system of
“disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is
designed to ensure that information which will be required to be disclosed by the Company in
reports that it files or
-9-
submits under the Exchange Act will be recorded, processed, summarized and reported within the
time periods specified in the Commission’s rules and forms, including controls and procedures
designed to ensure that such information will be accumulated and communicated to the Company’s
management as appropriate to allow timely decisions regarding required disclosure.
(aa) Accounting Controls. The Company and its subsidiaries maintain a system of “internal
control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply
with the requirements of the Exchange Act and have been designed by, or under the supervision of,
the Company’s executive and financial officers, and effected by the Company’s board of directors,
management and other personnel to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles, including those policies and procedures that (i)
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the
transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles and that receipts and expenditures of the Company are
being made in accordance with and authorizations of management and directors of the Company; and
(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the Company’s assets that could have a material effect on the
Company’s financial statements. Except as disclosed in the Registration Statement, the Time of
Sale Information and the Prospectus, there are no material weaknesses in the Company’s internal
controls.
(bb) Insurance. The Company and its subsidiaries have insurance covering their respective
properties, operations, personnel and businesses, which insurance is in reasonable amounts and
insures against such losses and risks as are reasonably adequate to protect the Company and its
subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries
has (i) received notice from any insurer or agent of such insurer that capital improvements or
other expenditures are required or necessary to be made in order to continue such insurance or (ii)
any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may
be necessary to continue its business.
(cc) No Unlawful Payments. Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company, any director, officer, agent, employee or other person associated with or
acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful expense relating to political
activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; (iii) violated or is in violation of any provision of
the Foreign Corrupt Practices Act of 1977; or (iv) made any bribe, rebate, payoff, influence
payment, kickback or other unlawful payment.
(dd) Compliance with Money Laundering Laws. The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or
enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit
or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is
pending or, to the knowledge of the Company, threatened.
(ee) Compliance with OFAC. None of the Company, any of its subsidiaries or, to the knowledge
of the Company, any director, officer, agent, employee or Affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets
-10-
Control of the U.S. Department of the Treasury (“OFAC”); and the Company will not directly or
indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any U.S.
sanctions administered by OFAC.
(ff) No Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited,
directly or indirectly, under any agreement or other instrument to which it is a party or is
subject, from paying any dividends to the Company, from making any other distribution on such
subsidiary’s capital stock, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary’s properties or assets to the Company
or any other subsidiary of the Company.
(gg) No Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to any
contract, agreement or understanding with any person (other than this Agreement) that would give
rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a
brokerage commission, finder’s fee or like payment in connection with the offering and sale of the
Shares.
(hh) No Registration Rights. Except as disclosed in the Registration Statement, the Time of
Sale Information and the Prospectus, no person has the right to require the Company or any of its
subsidiaries to register any securities for sale under the Securities Act by reason of the filing
of the Registration Statement with the Commission or the issuance and sale of the Shares.
(ii) No Stabilization. The Company has not taken, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Shares.
(jj) Margin Rules. Neither the issuance, sale and delivery of the Shares nor the application
of the proceeds thereof by the Company as described in the Registration Statement, the Time of Sale
Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the
Federal Reserve System or any other regulation of such Board of Governors.
(kk) Forward-Looking Statements. No forward-looking statement (within the meaning of Section
27A of the Securities Act and Section 21E of the Exchange Act) contained in the Registration
Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a
reasonable basis or has been disclosed other than in good faith.
(ll) Statistical and Market Data. Nothing has come to the attention of the Company that has
caused the Company to believe that the statistical and market-related data included in the
Registration Statement, the Time of Sale Information and the Prospectus is not based on or derived
from sources that are reliable and accurate in all material respects.
(mm) Xxxxxxxx-Xxxxx Act. There is and has been no failure on the part of the Company or any
of the Company’s directors or officers, in their capacities as such, to comply with any applicable
provision of the Xxxxxxxx-Xxxxx Act of 2002 and any applicable rules and regulations promulgated in
connection therewith (the “Xxxxxxxx-Xxxxx Act”), including Section 402 related to loans.
(nn) Status under the Securities Act. The Company is not an ineligible issuer as defined
under the Securities Act, at the times specified in the Securities Act in connection with the
offering of the Shares.
-11-
(oo) Reserve Data. (i) The oil and natural gas reserve estimates of the Company and its
subsidiaries as of December 31, 2004, 2005 and 2006 contained in the Registration Statement, the
Time of Sale Information and the Prospectus are derived from reports that have been prepared by, or
have been audited by, either (a) Netherland, Xxxxxx & Associates, Inc. or (b) Xxxxxx, Xxxxxxxxx &
Associates, Inc., as set forth and to the extent indicated therein, and such estimates fairly
reflect the oil and natural gas reserves of the Company and its subsidiaries, as applicable, at the
dates indicated therein and are in accordance, in all material respects, with Commission guidelines
applied on a consistent basis throughout the periods involved; and
(ii) The oil and natural gas reserve estimates of the Chase Group Properties as of December
31, 2003, 2004 and 2005 contained in the Registration Statement, the Time of Sale Information and
the Prospectus are derived from reports that have been prepared by, or have been audited by Xxxxxx,
Xxxxxxxxx & Associates, Inc., as set forth therein, and such estimates fairly reflect the oil and
natural gas reserves of the Chase Group Properties, at the dates indicated therein and are in
accordance, in all material respects, with Commission guidelines applied on a consistent basis
throughout the periods involved.
(pp) Independent Petroleum Engineers. Each of Netherland, Xxxxxx & Associates, Inc. and
Xxxxxx, Xxxxxxxxx & Associates, Inc. have represented to the Company that they are, and the Company
believes them to be, independent petroleum engineers with respect to the Company and its
subsidiaries and for the periods set forth in the Registration Statement, the Time of Sale
Information and the Prospectus.
4. Representations and Warranties of the Selling Stockholders. (i) The Chase
Stockholders represent and warrant, jointly and severally, to each Underwriter and the Company
that:
(a) Required Consents; Authority. All consents, approvals, authorizations and orders
necessary for the execution and delivery by such Chase Stockholder of this Agreement and the Power
of Attorney (the “Power of Attorney”) and the Custody Agreement (the “Custody Agreement”)
hereinafter referred to, and for the sale and delivery of the Shares to be sold by such Chase
Stockholder hereunder, have been obtained; and such Chase Stockholder has full right, power and
authority to enter into this Agreement, the Power of Attorney and the Custody Agreement and to
sell, assign, transfer and deliver the Shares to be sold by such Chase Stockholder hereunder; this
Agreement, the Power of Attorney and the Custody Agreement have each been duly authorized, executed
and delivered by such Chase Stockholder.
(b) No Conflicts. The execution, delivery and performance by such Chase Stockholder of this
Agreement, the Power of Attorney and the Custody Agreement, the sale of the Shares to be sold by
such Chase Stockholder and the consummation by such Chase Stockholder of the transactions herein
and therein contemplated will not (i) conflict with or result in a breach or violation of any of
the terms or provisions of, or constitute a default under, or result in the creation or imposition
of any lien, charge or encumbrance upon any property or assets of such Chase Stockholder pursuant
to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to
which such Chase Stockholder is a party or by which such Chase Stockholder is bound or to which any
of the property or assets of such Chase Stockholder is subject, (ii) result in any violation of the
provisions of the charter or by-laws or similar organizational documents of such Chase Stockholder
or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation
of any court or arbitrator or governmental or regulatory agency.
(c) Title to Shares. Such Chase Stockholder has good and valid title to the Shares to be sold
at the Closing Date or the Additional Closing Date, as the case may be, by such Chase Stockholder
hereunder, free and clear of all liens, encumbrances, equities or adverse claims; such Chase
Stockholder will have, immediately prior to the Closing Date or the Additional Closing Date, as the
case may be, good and valid title to the Shares to be sold at the Closing Date or the Additional
Closing Date, as the case may be,
-12-
by such Chase Stockholder, free and clear of all liens, encumbrances, equities or adverse
claims; and, upon delivery of the certificates representing such Shares and payment therefor
pursuant hereto, good and valid title to such Shares, free and clear of all liens, encumbrances,
equities or adverse claims, will pass to the several Underwriters.
(d) No Stabilization. Such Chase Stockholder has not taken and will not take, directly or
indirectly, any action designed to or that could reasonably be expected to cause or result in any
stabilization or manipulation of the price of the Shares.
(e) Time of Sale Information. The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; provided, however, that the representations and warranties set forth in
this paragraph are limited to statements or omissions made in reliance upon information relating to
Chase Oil Corporation, Caza Energy LLC, their stockholders and affiliates, the Chase Group
Properties and the Chase Group Properties financial statements (collectively, the “Time of Sale
Chase Information”).
(f) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the Prospectus,
such Chase Stockholder (including its agents and representatives) has not made, used, prepared,
authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to
any Issuer Free Writing Prospectus, other than (i) any document not constituting a prospectus
pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii)
the documents listed on Annex B hereto and other written communications approved in writing in
advance by the Company and the Representatives.
(g) Registration Statement and Prospectus. As of the applicable effective date of the
Registration Statement and any amendment thereto, the Registration Statement complied and will
comply in all material respects with the Securities Act, and did not and will not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein not misleading; and as of the date of the
Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the
Additional Closing Date, as the case may be, the Prospectus will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; provided, however, that the representations and warranties set
forth in this paragraph are limited to information contained in the Registration Statement,
Prospectus (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus relating
to Chase Oil Corporation, Caza Energy LLC, their stockholders and affiliates, the Chase Group
Properties and the Chase Group Properties financial statements included in the Prospectus
(collectively, the “Registration Statement Chase Information,” and together with the Time of Sale
Chase Information, the “Chase Information”).
(h) Material Information. As of the date hereof, as of the Closing Date and as of the
Additional Closing Date, as the case may be, the sale of the Shares by such Chase Stockholder is
not and will not be prompted by any material information concerning the Company which is not set
forth in the Registration Statement, the Time of Sale Information or the Prospectus.
(ii) Each Chase Stockholder represents and warrants to each Underwriter and the
Company that certificates in negotiable form representing all of the Shares to be sold by such
Chase Stockholder hereunder have been placed in custody under a Custody Agreement relating to such
Shares, in the form
-13-
heretofore furnished to you, duly executed and delivered by such Chase Stockholder to [
], as custodian (the “Custodian”), and that such Chase Stockholder has duly executed and
delivered a Power of Attorney, in the form heretofore furnished to you, appointing the person or
persons indicated in Schedule 3 hereto, and each of them, as such Chase Stockholder’s
Attorneys-in-fact (the “Chase Attorneys-in-Fact” or any one of them, the “Chase Attorney-in-Fact”)
with authority to execute and deliver this Agreement on behalf of such Chase Stockholder, to
determine the purchase price to be paid by the Underwriters to the Chase Stockholders as provided
herein, to authorize the delivery of the Shares to be sold by such Chase Stockholder hereunder and
otherwise to act on behalf of such Chase Stockholder in connection with the transactions
contemplated by this Agreement and the Custody Agreement.
(iii) Each Chase Stockholder specifically agrees that the Shares represented by the
certificates held in custody for such Chase Stockholder under the Custody Agreement are subject to
the interests of the Underwriters hereunder, and that the arrangements made by such Chase
Stockholder for such custody, and the appointment by such Chase Stockholder of the Chase
Attorneys-in-Fact by the Power of Attorney, are to that extent irrevocable. Each Chase Stockholder
specifically agrees that the obligations of such Chase Stockholder hereunder shall not be
terminated by operation of law, whether by the death or incapacity of any individual Chase
Stockholder, or, in the case of an estate or trust, by the death or incapacity of any executor or
trustee or the termination of such estate or trust, or in the case of a partnership, corporation or
similar organization, by the dissolution of such partnership, corporation or organization, or by
the occurrence of any other event. If any individual Chase Stockholder or any such executor or
trustee should die or become incapacitated, or if any such estate or trust should be terminated, or
if any such partnership, corporation or similar organization should be dissolved, or if any other
such event should occur, before the delivery of the Shares hereunder, certificates representing
such Shares shall be delivered by or on behalf of such Chase Stockholder in accordance with the
terms and conditions of this Agreement and the Custody Agreement, and actions taken by the Chase
Attorneys-in-Fact pursuant to the Powers of Attorney shall be as valid as if such death,
incapacity, termination, dissolution or other event had not occurred, regardless of whether or not
the Custodian, the Chase Attorneys-in-Fact, or any of them, shall have received notice of such
death, incapacity, termination, dissolution or other event.
(iv) The Non-Chase Stockholders represent and warrant, jointly and severally, to each
Underwriter and the Company that:
(a) Required Consents; Authority. All consents, approvals, authorizations and orders
necessary for the execution and delivery by such Non-Chase Stockholder of this Agreement and the
Power of Attorney (the “Power of Attorney”) and the Custody Agreement (the “Custody Agreement”)
hereinafter referred to, and for the sale and delivery of the Shares to be sold by such Non-Chase
Stockholder hereunder, have been obtained; and such Non-Chase Stockholder has full right, power and
authority to enter into this Agreement, the Power of Attorney and the Custody Agreement and to
sell, assign, transfer and deliver the Shares to be sold by such Non-Chase Stockholder hereunder;
this Agreement, the Power of Attorney and the Custody Agreement have each been duly authorized,
executed and delivered by such Non-Chase Stockholder.
(b) No Conflicts. The execution, delivery and performance by such Non-Chase Stockholder of
this Agreement, the Power of Attorney and the Custody Agreement, the sale of the Shares to be sold
by such Non-Chase Stockholder and the consummation by such Non-Chase Stockholder of the
transactions herein and therein contemplated will not (i) conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property or assets of such
Non-Chase Stockholder pursuant to, any indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument to which such Non-Chase Stockholder is a party or by which such Non-Chase
Stockholder is bound or to which any of the
-14-
property or assets of such Non-Chase Stockholder is subject, (ii) result in any violation of
the provisions of the charter or by-laws or similar organizational documents of such Non-Chase
Stockholder or (iii) result in the violation of any law or statute or any judgment, order, rule or
regulation of any court or arbitrator or governmental or regulatory agency.
(c) Title to Shares. Such Non-Chase Stockholder has good and valid title to the Shares to be
sold at the Closing Date or the Additional Closing Date, as the case may be, by such Non-Chase
Stockholder hereunder, free and clear of all liens, encumbrances, equities or adverse claims; such
Non-Chase Stockholder will have, immediately prior to the Closing Date or the Additional Closing
Date, as the case may be, good and valid title to the Shares to be sold at the Closing Date or the
Additional Closing Date, as the case may be, by such Non-Chase Stockholder, free and clear of all
liens, encumbrances, equities or adverse claims; and, upon delivery of the certificates
representing such Shares and payment therefor pursuant hereto, good and valid title to such Shares,
free and clear of all liens, encumbrances, equities or adverse claims, will pass to the several
Underwriters.
(d) No Stabilization. Such Non-Chase Stockholder has not taken and will not take, directly or
indirectly, any action designed to or that could reasonably be expected to cause or result in any
stabilization or manipulation of the price of the Shares.
(e) Time of Sale Information. The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; provided, however, that the representations and warranties set forth in
this paragraph are limited to statements or omissions made in reliance upon information relating to
such Non-Chase Stockholder furnished to the Company in writing by such Non-Chase Stockholder
expressly for use in the Time of Sale Information (the “ Non-Chase Stockholder Time of Sale
Information”).
(f) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the Prospectus,
such Non-Chase Stockholder (including its agents and representatives, other than the Underwriters
in their capacity as such) has not made, used, prepared, authorized, approved or referred to and
will not prepare, make, use, authorize, approve or refer to any Issuer Free Writing Prospectus,
other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the
Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex B hereto
and other written communications approved in writing in advance by the Company and the
Representatives.
(g) Registration Statement and Prospectus. As of the applicable effective date of the
Registration Statement and any amendment thereto, the Registration Statement complied and will
comply in all material respects with the Securities Act, and did not and will not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein not misleading; and as of the date of the
Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the
Additional Closing Date, as the case may be, the Prospectus will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; provided, however, that the representations and warranties set
forth in this paragraph are limited to statements or omissions made in reliance upon information
relating to such Non-Chase Stockholder furnished to the Company in writing by such Non-Chase
Stockholder expressly for the use in the Registration Statement, Prospectus (or any amendment or
supplement thereto) or any Issuer Free Writing Prospectus (the “Non-Chase Stockholder Registration
Statement Information”,
-15-
and together with the Non-Chase Stockholder Time of Sale Information, the “Non-Chase
Stockholder Information”).
(h) Material Information. As of the date hereof, as of the Closing Date and as of the
Additional Closing Date, as the case may be, the sale of the Shares by such Non-Chase Stockholder
is not and will not be prompted by any material information concerning the Company which is not set
forth in the Registration Statement, the Time of Sale Information or the Prospectus.
(v) Each Non-Chase Stockholder represents and warrants to each Underwriter and the
Company that certificates in negotiable form representing all of the Shares to be sold by such
Non-Chase Stockholder hereunder have been placed in custody under a Custody Agreement relating to
such Shares, in the form heretofore furnished to you, duly executed and delivered by such Non-Chase
Stockholder to [ ], as custodian (the “Custodian”), and that such Non-Chase Stockholder has
duly executed and delivered a Power of Attorney, in the form heretofore furnished to you,
appointing the person or persons indicated in Schedule 4 hereto, and each of them, as such
Non-Chase Stockholder’s Attorneys-in-fact (the “Non-Chase Attorneys-in-Fact” or any one of them the
“Non-Chase Attorney-in Fact”) with authority to execute and deliver this Agreement on behalf of
such Non-Chase Stockholder, to determine the purchase price to be paid by the Underwriters to the
Non-Chase Stockholders as provided herein, to authorize the delivery of the Shares to be sold by
such Non-Chase Stockholder hereunder and otherwise to act on behalf of such Non-Chase Stockholder
in connection with the transactions contemplated by this Agreement and the Custody Agreement.
(vi) Each Non-Chase Stockholder specifically agrees that the Shares represented by the
certificates held in custody for such Non-Chase Stockholder under the Custody Agreement are subject
to the interests of the Underwriters hereunder, and that the arrangements made by such Non-Chase
Stockholder for such custody, and the appointment by such Non-Chase Stockholder of the Non-Chase
Attorneys-in-Fact by the Power of Attorney, are to that extent irrevocable. Each Non-Chase
Stockholder specifically agrees that the obligations of such Non-Chase Stockholder hereunder shall
not be terminated by operation of law, whether by the death or incapacity of any individual
Non-Chase Stockholder, or, in the case of an estate or trust, by the death or incapacity of any
executor or trustee or the termination of such estate or trust, or in the case of a partnership,
corporation or similar organization, by the dissolution of such partnership, corporation or
organization, or by the occurrence of any other event. If any individual Non-Chase Stockholder or
any such executor or trustee should die or become incapacitated, or if any such estate or trust
should be terminated, or if any such partnership, corporation or similar organization should be
dissolved, or if any other such event should occur, before the delivery of the Shares hereunder,
certificates representing such Shares shall be delivered by or on behalf of such Non-Chase
Stockholder in accordance with the terms and conditions of this Agreement and the Custody
Agreement, and actions taken by the Non-Chase Attorneys-in-Fact pursuant to the Powers of Attorney
shall be as valid as if such death, incapacity, termination, dissolution or other event had not
occurred, regardless of whether or not the Custodian, the Non-Chase Attorneys-in-Fact, or any of
them, shall have received notice of such death, incapacity, termination, dissolution or other
event.
5. Further Agreements of the Company. The Company covenants and agrees with each
Underwriter and each Selling Stockholder that:
(a) Required Filings. The Company will file the final Prospectus with the Commission within
the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act,
will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the
Securities Act; and the Company will furnish copies of the Prospectus and each Issuer Free Writing
Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to
10:00 A.M., New York
-16-
City time, on the business day next succeeding the date of this Agreement in such quantities
as the Representatives may reasonably request.
(b) Delivery of Copies. The Company will deliver, without charge, (i) to the Representatives,
three signed copies of the Registration Statement as originally filed and each amendment thereto,
in each case including all exhibits and consents filed therewith; and (ii) to each Underwriter (A)
a conformed copy of the Registration Statement as originally filed and each amendment thereto
(without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies
of the Prospectus (including all amendments and supplements thereto) and each Issuer Free Writing
Prospectus as the Representatives may reasonably request. As used herein, the term “Prospectus
Delivery Period” means such period of time after the first date of the public offering of the
Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is
required by law to be delivered (or required to be delivered but for Rule 172 under the Securities
Act) in connection with sales of the Shares by any Underwriter or dealer.
(c) Amendments or Supplements, Issuer Free Writing Prospectuses. Before preparing, using,
authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before
filing any amendment or supplement to the Registration Statement or the Prospectus, the Company
will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer
Free Writing Prospectus, amendment or supplement for review and will not prepare, use, authorize,
approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed
amendment or supplement to which the Representatives reasonably object.
(d) Notice to the Representatives. The Company will advise the Representatives promptly, and
confirm such advice in writing, (i) when the Registration Statement has become effective; (ii) when
any amendment to the Registration Statement has been filed or becomes effective; (iii) when any
supplement to the Prospectus or any Issuer Free Writing Prospectus or any amendment to the
Prospectus has been filed; (iv) of any request by the Commission for any amendment to the
Registration Statement or any amendment or supplement to the Prospectus or the receipt of any
comments from the Commission relating to the Registration Statement or any other request by the
Commission for any additional information; (v) of the issuance by the Commission of any order
suspending the effectiveness of the Registration Statement or preventing or suspending the use of
any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for
that purpose or pursuant to Section 8A of the Securities Act; (vi) of the occurrence of any event
within the Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale
Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances existing
when the Prospectus, the Time of Sale Information or any such Issuer Free Writing Prospectus is
delivered to a purchaser, not misleading; and (vii) of the receipt by the Company of any notice
with respect to any suspension of the qualification of the Shares for offer and sale in any
jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company
will use its best efforts to prevent the issuance of any such order suspending the effectiveness of
the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the
Prospectus or suspending any such qualification of the Shares and, if any such order is issued,
will obtain as soon as possible the withdrawal thereof.
(e) Ongoing Compliance. (1) If during the Prospectus Delivery Period (i) any event shall
occur or condition shall exist as a result of which the Prospectus as then amended or supplemented
would include any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it
is necessary to amend or
-17-
supplement the Prospectus to comply with law, the Company will immediately notify the Underwriters
thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and
furnish to the Underwriters and to such dealers as the Representatives may designate, such
amendments or supplements to the Prospectus as may be necessary so that the statements in the
Prospectus as so amended or supplemented will not, in the light of the circumstances existing when
the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply
with law and (2) if at any time prior to the Closing Date (i) any event shall occur or condition
shall exist as a result of which the Time of Sale Information as then amended or supplemented would
include any untrue statement of a material fact or omit to state any material fact necessary in
order to make the statements therein, in the light of the circumstances, not misleading or (ii) it
is necessary to amend or supplement the Time of Sale Information to comply with law, the Company
will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph
(c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to
such dealers as the Representatives may designate, such amendments or supplements to the Time of
Sale Information as may be necessary so that the statements in the Time of Sale Information as so
amended or supplemented will not, in the light of the circumstances, be misleading or so that the
Time of Sale Information will comply with law.
(f) Blue Sky Compliance. The Company will qualify the Shares for offer and sale under the
securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request
and will continue such qualifications in effect so long as required for distribution of the Shares;
provided that the Company shall not be required to (i) qualify as a foreign corporation or
other entity or as a dealer in securities in any such jurisdiction which it would not otherwise be
required to so qualify, (ii) file any general consent to service of process in any such
jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so
subject.
(g) Earning Statement. The Company will make generally available to its security holders and
the Representatives as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first fiscal quarter of the Company occurring
after the “effective date” (as defined in Rule 158) of the Registration Statement.
(h) Clear Market. For a period of 180 days after the date of the initial public offering of
the Shares, the Company will not (i) offer, pledge, announce the intention to sell, sell, contract
to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant
any option, right or warrant to purchase or otherwise transfer or dispose of, directly or
indirectly, any shares of Stock or any securities convertible into or exercisable or exchangeable
for Stock or (ii) enter into any swap or other agreement that transfers, in whole or in part, any
of the economic consequences of ownership of the Stock, whether any such transaction described in
clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash or
otherwise, without the prior written consent of the Representatives, other than (A) the Shares to
be sold hereunder, (B) any shares of Stock of the Company issued upon the exercise of options
granted under existing employee stock option plans; provided, however, that once issued, each
distributee shall execute and deliver to the Representatives a lock-up letter in the form of this
paragraph, (C) grants by the Company of any employee stock options or restricted stock in
accordance with the terms of the 2006 Stock Incentive Plan effective June 1, 2006 as in effect on
the date hereof (the “Plan”) and (D) the filing by the Company of any registration statement with
the Commission on Form S-8 relating to the offering of securities pursuant to the terms of the
Plan. Notwithstanding the foregoing, if (1) during the last 17 days of the 180-day restricted
period, the Company issues an earnings release or material news or a material event relating to the
Company occurs; or (2) prior to the expiration of the 180-day restricted period, the Company
announces that it will release earnings results during the 16-day period beginning on the last day
of the 180-day period, the restrictions imposed by this Agreement shall continue to apply
-18-
until the expiration of the 18-day period beginning on the issuance of the earnings release or
the occurrence of the material news or material event.
(i) Use of Proceeds. The Company will apply the net proceeds from the sale of the Shares as
described in the Registration Statement, the Time of Sale Information and the Prospectus under the
heading “Use of Proceeds”.
(j) No Stabilization. The Company will not take, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Shares.
(k) Exchange Listing. The Company will use its best efforts to list, subject to notice of
issuance, the Shares on the New York Stock Exchange (the “Exchange”).
(l) Reports. So long as the Shares are outstanding, the Company will furnish to the
Representatives, as soon as they are available, copies of all reports or other communications
(financial or other) furnished to holders of the Shares, and copies of any reports and financial
statements furnished to or filed with the Commission or any national securities exchange or
automatic quotation system.
(m) Record Retention. The Company will, pursuant to reasonable procedures developed in good
faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission
in accordance with Rule 433 under the Securities Act.
(n) Filings. The Company will file with the Commission such reports as may be required by
Rule 463 under the Securities Act.
6. Further Agreements of Selling Stockholders. Each Selling Stockholder covenants and
agrees with each Underwriter and the Company that:
(a) Clear Market. For a period of 180 days after the date of the Prospectus, such Selling
Stockholder will not (i) offer, pledge, announce the intention to sell, sell, contract to sell,
sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, any
shares of Stock or any securities convertible into or exercisable or exchangeable for Stock or (ii)
enter into any swap or other agreement that transfers, in whole or in part, any of the economic
consequences of ownership of the Stock, whether any such transaction described in clause (i) or
(ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise or
(iii) make any demand for or exercise any right with respect to the registration of any shares of
Stock or any security convertible into or exercisable or exchangeable for Stock without the prior
written consent of the Representatives, in each case other than (A) the Shares to be sold by such
Selling Stockholder hereunder, (B) transfers of shares of Stock as a bona fide gift or gifts,
including to the Chase Foundation, (C) transfers of shares of Stock or other securities to
directors, officers or employees of Chase Oil Corporation or its subsidiaries or affiliates and (D)
distributions of shares of Stock to members or stockholders of such Selling Stockholder; provided
that in the case of any transfer or distribution pursuant to clauses (B), (C), or (D) each donee,
transferee or distributee shall execute and deliver to the Representatives a lock-up letter in the
form of this paragraph and provided, further, that in the case of any transfer or distribution
pursuant to clauses (B) or (D) no filing by any party (donor, donee, transferor or transferee)
under Section 16(a) of the Securities Exchange Act of 1934, as amended, shall be required or shall
be made voluntarily in connection with such transfer or distribution (other than a filing on a Form
5 made after the expiration of the 180-day period referred to above). Notwithstanding the
foregoing, if (i) during the last 17 days of the 180-day restricted period, the Company issues an
earnings release or material news or a material event relating to the Company occurs; or (ii) prior
to the expiration of
-19-
the 180-day restricted period, the Company announces that it will release earnings results
during the 16-day period beginning on the last day of the 180-day period, the restrictions imposed
by this Agreement shall continue to apply until the expiration of the 18-day period beginning on
the issuance of the earnings release or the occurrence of the material news or material event;
provided, however, that in no event shall such restrictions extend past 214 days from the date of
the Prospectus.
(b) Tax Form. It will deliver to the Representatives prior to or at the Closing Date a
properly completed and executed United States Treasury Department Form W-9 (or other applicable
form or statement specified by the Treasury Department regulations in lieu thereof) in order to
facilitate the Underwriters’ documentation of their compliance with the reporting and withholding
provisions of the Tax Equity and Fiscal Responsibility Act of 1982 with respect to the transactions
herein contemplated.
7. Certain Agreements of the Underwriters. Each Underwriter hereby represents and
agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in the planning
for use of, any “free writing prospectus”, as defined in Rule 405 under the Securities Act (which
term includes use of any written information furnished to the Commission by the Company and not
incorporated by reference into the Registration Statement and any press release issued by the
Company) other than (i) a free writing prospectus that contains no “issuer information” (as defined
in Rule 433(h)(2) under the Securities Act) that was not included (including through incorporation
by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus,
(ii) any Issuer Free Writing Prospectus listed on Annex C or prepared pursuant to Section 3(c) or
Section 5(c) above, or (iii) any free writing prospectus prepared by such underwriter and approved
by the Company in advance in writing (each such free writing prospectus referred to in clauses (i)
or (iii), an “Underwriter Free Writing Prospectus”).
(b) It has not and will not distribute any Underwriter Free Writing Prospectus referred to in
clause (a)(i) in a manner reasonably designed to lead to its broad unrestricted dissemination.
(c) It has not and will not, without the prior written consent of the Company, use any free
writing prospectus that contains the final terms of the Shares unless such terms have previously
been included in a free writing prospectus filed with the Commission; provided that
Underwriters may use a term sheet substantially in the form of Annex D hereto without the consent
of the Company; provided further that any Underwriter using such term sheet shall
notify the Company, and provide a copy of such term sheet to the Company, prior to, or
substantially concurrently with, the first use of such term sheet.
(d) It will, pursuant to reasonable procedures developed in good faith, retain copies of each
free writing prospectus used or referred to by it, in accordance with Rule 433 under the Securities
Act.
(e) It is not subject to any pending proceeding under Section 8A of the Securities Act with
respect to the offering (and will promptly notify the Company and the Selling Stockholders if any
such proceeding against it is initiated during the Prospectus Delivery Period).
8. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to
purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing
Date, as the case may be, as provided herein is subject to the performance by the Company and the
Selling Stockholders of their respective covenants and other obligations hereunder and to the
following additional conditions:
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose or pursuant to
Section 8A
-20-
under the Securities Act shall be pending before or threatened by the Commission; the
Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission
under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required
by Rule 433 under the Securities Act) and in accordance with Section 5(a) hereof; and all requests
by the Commission for additional information shall have been complied with to the reasonable
satisfaction of the Representatives.
(b) Representations and Warranties. The representations and warranties of the Company and the
Selling Stockholders contained herein shall be true and correct on the date hereof and on and as of
the Closing Date or the Additional Closing Date, as the case may be; and the statements of the
Company and its officers made in any certificates delivered pursuant to this Agreement shall be
true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be.
(c) No Downgrade. Subsequent to the execution and delivery of this Agreement, (i) no
downgrading shall have occurred in the rating accorded any securities or preferred stock of or
guaranteed by the Company or any of its subsidiaries by any “nationally recognized statistical
rating organization”, as such term is defined by the Commission for purposes of Rule 436(g)(2)
under the Securities Act and (ii) no such organization shall have publicly announced that it has
under surveillance or review, or has changed its outlook with respect to, its rating of any
securities or preferred stock of or guaranteed by the Company or any of its subsidiaries (other
than an announcement with positive implications of a possible upgrading).
(d) No Material Adverse Change. No event or condition of a type described in Section 3(f)
hereof shall have occurred or shall exist, which event or condition is not described in the Time of
Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any
amendment or supplement thereto) and the effect of which in the judgment of the Representatives
makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares
on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the
manner contemplated by this Agreement, the Time of Sale Information and the Prospectus.
(e) Officer’s Certificate. The Representatives shall have received on and as of the Closing
Date or the Additional Closing Date, as the case may be, a certificate of each of (i) the chief
financial officer or chief accounting officer of the Company and one additional senior executive
officer of the Company who is satisfactory to the Representatives (A) confirming that such officers
have carefully reviewed the Registration Statement, the Time of Sale Information and the Prospectus
and, to the knowledge of such officers, the representations set forth in Sections 3(b) and 3(d)
hereof are true and correct, (B) confirming that the other representations and warranties of the
Company in this Agreement are true and correct and that the Company has complied with all
agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or
prior to such Closing Date and (C) to the effect set forth in paragraphs (a), (c) and (d) above and
(ii) the Selling Stockholders, in form and substance reasonably satisfactory to the
Representatives, (A) confirming that the representations of such Selling Stockholder set forth in
Sections 4(e), 4(f) and 4(g) hereof is true and correct and (B) confirming that the other
representations and warranties of such Selling Stockholder in this agreement are true and correct
and that such Selling Stockholder has complied with all agreements and satisfied all conditions on
their part to be performed or satisfied hereunder at or prior to such Closing Date.
(f) Comfort Letters. On the date of this Agreement and on the Closing Date or the Additional
Closing Date, as the case may be, Xxxxx Xxxxxxxx LLP shall have furnished to the Representatives,
at the request of the Company, letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representatives, containing statements and information of the type customarily included in
accountants’ “comfort letters” to underwriters with
-21-
respect to the financial statements and certain
financial information contained in the Registration Statement, the Time of Sale Information and the
Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date,
as the case may be, shall use a “cut-off” date no more than three business days prior to such
Closing Date or such Additional Closing Date, as the case may be.
(g) Reserve Letters. On the date of this Agreement and on the Closing Date or the Additional
Closing Date, as the case may be, each of Netherland, Xxxxxx & Associates, Inc. and Xxxxxx,
Xxxxxxxxx & Associates, Inc. shall have furnished to the Representatives, at the request of the
Company, reserve report confirmation letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representatives, containing statements and information of the type customarily included in such
letters to underwriters with respect to the reserve and other operational information contained in
the Registration Statement, the Time of Sale Information and the Prospectus.
(h) Opinion of Counsel for the Company. Xxxxxx & Xxxxxx L.L.P., counsel for the Company,
shall have furnished to the Representatives, at the request of the Company, their written opinion,
dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect
set forth in Annex A hereto.
(i) Opinions of Counsel for Selling Stockholders. Each of (i) Xxxxxxxxx & Xxxxxxxx, LLP,
counsel for the Chase Stockholders, and (ii) Xxxxxx & Xxxxxx L.L.P., counsel for the Non-Chase
Stockholders, shall have furnished the Representatives, at the request of the Selling Stockholders,
their written opinion, dated the Closing Date, or Additional Closing Date, in the case of Xxxxxxxxx
& Xxxxxxxx, LLP, if applicable, and addressed to the Underwriters, in form and substance reasonably
satisfactory to the Representatives, to the effect set forth in Annex B hereto.
(j) Opinion of Counsel for the Underwriters. The Representatives shall have received on and
as of the Closing Date or the Additional Closing Date, as the case may be, an opinion of Xxxxxx
Xxxxxx & Xxxxxxx llp, counsel for the Underwriters, with respect to such matters as the
Representatives may reasonably request, and such counsel shall have received such documents and
information as they may reasonably request to enable them to pass upon such matters.
(k) No Legal Impediment to Issuance. No action shall have been taken and no statute, rule,
regulation or order shall have been enacted, adopted or issued by any federal, state or foreign
governmental or regulatory authority that would, as of the Closing Date or the Additional Closing
Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order of
any federal, state or foreign court shall have been issued that would, as of the Closing Date or
the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares.
(l) Good Standing. The Representatives shall have received on and as of the Closing Date or
the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the
Company and its subsidiaries in their respective jurisdictions of organization and their good
standing as foreign entities in such other jurisdictions as the Representatives may reasonably
request, in each case in writing or any standard form of telecommunication from the appropriate
Governmental Authorities of such jurisdictions.
(m) Exchange Listing. The Shares to be delivered on the Closing Date or Additional Closing
Date, as the case may be, shall have been approved for listing on the Exchange, subject to official
notice of issuance.
-22-
(n) Lock-up Agreements. The “lock-up” agreements, each substantially in the form of Exhibit A
hereto, between you and certain shareholders, the Selling Stockholders, officers and directors of
the Company relating to sales and certain other dispositions of shares of Stock or certain other
securities, delivered to you on or before the date hereof, shall be in full force and effect on the
Closing Date or the Additional Closing Date, as the case may be.
(o) Additional Documents. On or prior to the Closing Date or the Additional Closing Date, as
the case may be, the Company and the Selling Stockholders shall have furnished to the
Representatives such further certificates and documents as the Representatives may reasonably
request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
9. Indemnification and Contribution.
(a) Indemnification of the Underwriters by Company. The Company agrees to indemnify and hold
harmless each Underwriter, its affiliates, directors and officers and each person, if any, who
controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act, from and against any and all losses, claims, damages and liabilities (including,
without limitation, legal fees and other expenses incurred in connection with any suit, action or
proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that
arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement or caused by any omission or alleged omission to state
therein a material fact required to be stated therein or necessary in order to make the statements
therein, not misleading, (ii) or any untrue statement or alleged untrue statement of a material
fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing
Prospectus or any Time of Sale Information (including any
Time of Sale Information that has subsequently been amended), or caused by any omission or
alleged omission to state therein a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading, in each case
except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any
untrue statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use therein, it being understood and
agreed that the only such information furnished by any Underwriter consists of the information
described as such in subsection (c) below.
The Company also agrees to indemnify and hold harmless UBS Securities LLC (“UBS Securities”),
its affiliates, directors and officers and each person, if any, who controls UBS Securities within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against
any and all losses, claims, damages and liabilities incurred as a result of UBS Securities’
participation as a “qualified independent underwriter” within the meaning of the Rules of Conduct
of the National Association of Securities Dealers, Inc. in connection with the offering of the
Shares.
(b) Indemnification of Underwriters by Selling Stockholders. (i) Each of the Non-Chase
Stockholders agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and
officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth
in paragraph (a) above for any and all Non-Chase Stockholder Information relating to such Non-Chase
Stockholder.
(ii) (A) Each of the Chase Stockholders agrees to indemnify and hold harmless each
Underwriter, its affiliates, directors and officers and each person, if any, who controls such
Underwriter within the
-23-
meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act to the same extent as the indemnity set forth in paragraph (a) above for any and all Chase
Information relating to such Chase Stockholder; and (B) the Chase Stockholders also agree, jointly
and severally, to indemnify and hold harmless each Underwriter, its affiliates, directors and
officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth
in paragraph (a) above for any and all Chase Information, provided, however, that the indemnity of
each Chase Stockholder under this clause (B) shall be limited to 50% of the net proceeds (after
deducting underwriting discounts but before deducting any other expenses) received by such Chase
Stockholder pursuant to its sale of Shares to the Underwriters pursuant to this Agreement.
(iii) Each of the Selling Stockholders severally in proportion to the number of Shares sold by
such Selling Stockholder hereunder also agrees to indemnify and hold harmless UBS Securities, its
affiliates, directors and officers and each person, if any, who controls UBS Securities within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any
and all losses, claims, damages and liabilities incurred as a result of UBS Securities’
participation as a “qualified independent underwriter” within the meaning of the Rules of Conduct
of the National Association of Securities Dealers, Inc. in connection with the offering of the
Shares.
(c) Indemnification of the Company and the Selling Stockholders. Each Underwriter agrees,
severally and not jointly, to indemnify and hold harmless the Company, each Selling Stockholder,
their directors, their officers who signed the Registration Statement and each person, if any, who
controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with
respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any
untrue statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to such
Underwriter furnished to the Company in writing by such Underwriter through the
Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment
or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, it
being understood and agreed upon that the only such information furnished by any Underwriter
consists of the following information in the Prospectus furnished on behalf of each Underwriter:
the concession and reallowance figures appearing in the fourth paragraph under the caption
“Underwriting” and the information contained in the seventh and eighth paragraphs under the caption
“Underwriting.”
(d) Notice and Procedures. If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in
respect of which indemnification may be sought pursuant to either paragraph (a), (b), or (c) above,
such person (the “Indemnified Person”) shall promptly notify the person against whom such
indemnification may be sought (the “Indemnifying Person”) in writing; provided that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have
under this Section 9 except to the extent that it has been materially prejudiced (through the
forfeiture of substantive rights or defenses) by such failure; and provided
further, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under this Section 9. If any
such proceeding shall be brought or asserted against an Indemnified Person and it shall have
notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified
Person, be counsel to the Indemnifying Person) to represent the Indemnified Person in such
proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as
incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless (i) the Indemnifying Person and the Indemnified Person shall
-24-
have mutually agreed to
the contrary or (ii) the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably satisfactory to the Indemnified Person. It is understood and agreed that the
Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to
any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid
or reimbursed as they are incurred; provided, however, that if indemnity may be
sought pursuant to the second paragraph of Section 9(a) above in respect of such proceeding, then
in addition to such separate firm of the Underwriters, their affiliates and such control persons of
the Underwriters the indemnifying party shall be liable for the fees and expenses of not more than
one separate firm (in addition to any local counsel) for UBS Securities in its capacity as a
“qualified independent underwriter”, its affiliates and all persons, if any, who control UBS
Securities within the meaning of either Section 15 of the Securities Act or Section 20 of the
Exchange Act. Any such separate firm for any Underwriter, its affiliates, directors and officers
and any control persons of such Underwriter shall be designated in writing by JPMorgan and any such
separate firm for the Company, its directors, its officers who signed the Registration Statement
and any control persons of the Company shall be designated in writing by the Company. The
Indemnifying Person shall not be liable for any settlement of any proceeding effected without its
written consent, but if settled with such consent or if there be a final judgment for the
plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any
loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing
sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person
reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this
paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected
without its written consent if (i) such settlement is entered into more than 30 days after receipt
by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have
reimbursed the Indemnified Person in accordance with such request prior to the date of such
settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person,
effect any settlement of any pending or threatened proceeding in respect of which any Indemnified
Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such
settlement (x) includes an unconditional release of such Indemnified Person, in form and substance
reasonably satisfactory to such Indemnified Person, from all liability on claims that are the
subject matter of such proceeding and (y) does not include any statement as to or any admission of
fault, culpability or a failure to act by or on behalf of any Indemnified Person.
(e) Contribution. If the indemnification provided for in paragraphs (a), (b), and (c) above
is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages
or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of
indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by
such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such
proportion as is appropriate to reflect the relative benefits received by the Company and the
Selling Stockholders, on the one hand, and the Underwriters or UBS Securities in its capacity as a
“qualified independent underwriter”, as the case may be, on the other, from the offering of the
Shares or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)
but also the relative fault of the Company and the Selling Stockholders, on the one hand, and the
Underwriters or UBS Securities in its capacity as a “qualified independent underwriter”, as the
case may be, on the other, in connection with the statements or omissions that resulted in such
losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
The relative benefits received by the Company and the Selling Stockholders, on the one hand, and
the Underwriters or UBS Securities in its capacity as a “qualified independent underwriter”, as the
case may be, on the other, shall be deemed to be in the same respective proportions as the net
proceeds (before deducting expenses) received by the Company and the Selling Stockholders from the
sale of the Shares and the total underwriting discounts and commissions received by the
Underwriters in connection therewith, in each case as set
-25-
forth in the table on the cover of the
Prospectus, or the fee to be received by UBS Securities in its capacity as a “qualified independent
underwriter”, as the case may be, bear to the aggregate offering price of the Shares. The relative
fault of the Company and the Selling Stockholders, on the one hand, and the Underwriters or UBS
Securities in its capacity as a “qualified independent underwriter”, as the case may be, on the
other, shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company and the Selling Stockholders or by the Underwriters
or UBS Securities in its capacity as a “qualified independent underwriter”, as the case may be, and
the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.
(f) Limitation on Liability. The Company, the Selling Stockholders and the Underwriters agree
that it would not be just and equitable if contribution pursuant to this Section 9 were determined
by pro rata allocation (even if the Selling Stockholders or the Underwriters were treated as one
entity for such purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in paragraph (e) above. The amount paid or payable by an
Indemnified Person as a result of the losses, claims, damages and liabilities referred to in
paragraph (e) above shall be deemed to include, subject to the limitations set forth above, any
legal or other expenses incurred by such Indemnified Person in connection with any such action or
claim. Notwithstanding the provisions of this Section 9, in no event shall an Underwriter be
required to contribute any amount in excess of the amount by which the total underwriting discounts
and commissions received by such Underwriter with respect to the offering of the Shares exceeds the
amount of any damages that such Underwriter has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The
Underwriters’ obligations to contribute pursuant to this Section 9 are several in proportion to
their respective purchase obligations hereunder and not joint. The liability of each Selling
Stockholder under such
Selling Stockholder’s representations, warranties and covenants and agreements contained in
Section 4 hereof and Section 6 hereof and under the indemnity and contribution provisions of this
Section 9 shall be limited to an amount equal to the net proceeds received by such Selling
Stockholder for the sale of Shares by such Selling Stockholder to the Underwriters pursuant to this
Agreement, provided, however, that the liability of the Chase Stockholders, other than pursuant to
Section 9(b)(ii)(A), with respect to Section 9(b)(ii), is limited as specified in Section
9(b)(ii)(B).
(g) Non-Exclusive Remedies. The remedies provided for in this Section 9 are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any Indemnified Person
at law or in equity.
10. Effectiveness of Agreement. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
11. Termination. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company and the Selling Stockholders, if after the execution and
delivery of this Agreement and prior to the Closing Date or, in the case of the Option Shares,
prior to the Additional Closing Date (i) trading generally shall have been suspended or materially
limited on or by any of the New York Stock Exchange, the American Stock Exchange, the National
Association of Securities Dealers, Inc., the Chicago Board Options Exchange, the Chicago Mercantile
Exchange or the Chicago Board of Trade; (ii) trading of any securities issued or guaranteed by the
Company shall have been suspended on any exchange or in any over-the-counter market; (iii) a
general moratorium on commercial banking activities shall have been declared by federal or New York
State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or
any change in financial markets or any calamity or
-26-
crisis, either within or outside the United
States, that, in the judgment of the Representatives, is material and adverse and makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the
Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner
contemplated by this Agreement, the Time of Sale Information and the Prospectus.
12. Defaulting Underwriter.
(a) If, on the Closing Date or the Additional Closing Date, as the case may be, any
Underwriter defaults on its obligation to purchase the Shares that it has agreed to purchase
hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the
purchase of such Shares by other persons satisfactory to the Company and the Selling Stockholders
on the terms contained in this Agreement. If, within 36 hours after any such default by any
Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then
the Company and the Selling Stockholders shall be entitled to a further period of 36 hours within
which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such
Shares on such terms. If other persons become obligated or agree to purchase the Shares of a
defaulting Underwriter, either the non-defaulting Underwriters or the Company and the Selling
Stockholders may postpone the Closing Date or the Additional Closing Date, as the case may be, for
up to five full business days in order to effect any changes that in the opinion of counsel for the
Company, counsel for the Selling Stockholders or counsel for the Underwriters may be necessary in
the Registration Statement and the Prospectus or in any other document or arrangement, and the
Company agrees to promptly prepare any amendment or supplement to the Registration Statement and
the Prospectus that effects any such changes. As used in this Agreement, the term “Underwriter”
includes, for all purposes of this Agreement unless the context otherwise requires, any person not
listed in Schedule 1 hereto that, pursuant to this Section 12, purchases Shares that a defaulting
Underwriter agreed but failed to purchase.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by the non-defaulting Underwriters and the Company and the Selling
Stockholders as provided in paragraph (a) above, the aggregate number of Shares that remain
unpurchased on the Closing Date or the Additional Closing Date, as the case may be does not exceed
one-eleventh of the aggregate number of Shares to be purchased on such date, then the Company and
the Selling Stockholders shall have the right to require each non-defaulting Underwriter to
purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus
such Underwriter’s pro rata share (based on the number of Shares that such Underwriter agreed to
purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such
arrangements have not been made.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by the non-defaulting Underwriters and the Company and the Selling
Stockholders as provided in paragraph (a) above, the aggregate number of Shares that remain
unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds
one-eleventh of the aggregate amount of Shares to be purchased on such date, or if the Company and
the Selling Stockholders shall not exercise the right described in paragraph (b) above, then this
Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to
purchase Shares on the Additional Closing Date, as the case may be, shall terminate without
liability on the part of the non-defaulting Underwriters. Any termination of this Agreement
pursuant to this Section 12 shall be without liability on the part of the Company, except that the
Company will continue to be liable for the payment of expenses as set forth in Section 13 hereof
and except that the provisions of Section 9 hereof shall not terminate and shall remain in effect.
-27-
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may
have to the Company, the Selling Stockholders or any non-defaulting Underwriter for damages caused
by its default.
13. Payment of Expenses. a) Whether or not the transactions contemplated by this
Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid
all costs and expenses incident to the performance of its obligations hereunder, including without
limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery
of the Shares and any taxes payable in that connection; (ii) the costs incident to the preparation,
printing and filing under the Securities Act of the Registration Statement, the Preliminary
Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus
(including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)
the costs of reproducing and distributing this Agreement; (iv) the fees and expenses of the
Company’s counsel and independent accountants; (v) the fees and expenses incurred in connection
with the registration or qualification and determination of eligibility for investment of the
Shares under the laws of such jurisdictions as the Representatives may designate and the
preparation, printing and distribution of a Blue Sky Survey, if requested by the Underwriters
(including the related reasonable fees and expenses of counsel for the Underwriters); (vi) the cost
of preparing stock certificates; (vii) the costs and charges of any transfer agent and any
registrar; (viii) all expenses and application fees incurred in connection with any filing with,
and clearance of the offering by, the National Association of Securities Dealers, Inc.; (ix) all
expenses incurred by the Company in connection with any “road show” presentation to potential
investors; and (x) all expenses and application fees related to the listing of the Shares on the
New York Stock Exchange
(a) If (i) this Agreement is terminated pursuant to Section 11, (ii) the Company or the
Selling Stockholders for any reason fails to tender the Shares for delivery to the Underwriters or
(iii) the Underwriters decline to purchase the Shares for any reason permitted under this
Agreement, the Company agrees to reimburse the Underwriters for all out-of-pocket costs and
expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this
Agreement and the offering contemplated hereby.
14. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and the officers
and directors and any controlling persons referred to in Section 9 hereof. Nothing in this
Agreement is intended or shall be construed to give any other person any legal or equitable right,
remedy or claim under or in respect of this Agreement or any provision contained herein. No
purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such
purchase.
15. Survival. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company, the Selling Stockholders and the Underwriters contained
in this Agreement or made by or on behalf of the Company, the Selling Stockholders or the
Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive
the delivery of and payment for the Shares and shall remain in full force and effect, regardless of
any termination of this Agreement or any investigation made by or on behalf of the Company, the
Selling Stockholders or the Underwriters.
16. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise
expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities
Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; and (c) the term “subsidiary” has the meaning set forth in
Rule 405 under the Securities Act .
-28-
17. Miscellaneous.
(a) Authority of the Representatives. Any action by the Underwriters hereunder may be taken
by the Representatives on behalf of the Underwriters, and any such action taken by Representatives
shall be binding upon the Underwriters.
(b) Notices. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted and confirmed by any standard form of
telecommunication. Notices to the Underwriters shall be given to the Representatives c/o X.X.
Xxxxxx Securities Inc., 000 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (fax: (000) 000-0000); Attention:
Equity Syndicate Desk, with a copy to Xxxxxx X. Xxxxxxxxx, Xxxxxx Xxxxxx & Xxxxxxx LLP, 00
Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (fax: (000) 000-0000). Notices to the Company shall be
given to it at Concho Resources Inc., 000 X. Xxxxx Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, (fax:
(000) 000-0000); Attention: Xxxxx X. Xxxxxxxx, Vice President and General Counsel, with a copy to
T. Xxxx Xxxxx, Xxxxxx & Xxxxxx L.L.P., 0000 Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000 (fax: ( ) ).
Notice to the Chase Stockholders shall be given to the Chase Attorney-in-Fact at [ ],
[ ], [ ], (fax: ); Attention: [ ], with a copy to Xxxxxxx
X. Xxxxxxxx, Xxxxxxxxx & Xxxxxxxx LLP, 000 Xxxxxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000
(fax: ( ) ). Notice to the Non-Chase Stockholders shall be given to the Non-Chase
Attorney-in-Fact at [ ], [ ], [ ], (Fax: ); Attention: [
], with a copy to [ ].
(c) Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of New York.
(d) Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
(e) Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same
shall be in writing and signed by the parties hereto.
(f) Headings. The headings herein are included for convenience of reference only and are not
intended to be part of, or to affect the meaning or interpretation of, this Agreement.
-29-
If the foregoing is in accordance with your understanding, please indicate your
acceptance of this Agreement by signing in the space provided below.
| Very truly yours, | ||||||
| CONCHO RESOURCES INC. | ||||||
| By | ||||||
| Title: | ||||||
S-1
| SELLING STOCKHOLDERS | ||||||
| By | ||||||
| As Attorney-in-Fact acting on behalf of each of the Selling Stockholders named in Schedule 3 to this Agreement | ||||||
S-2
| SELLING STOCKHOLDERS | ||||||
| By | ||||||
| Name: | ||||||
| As Attorney-in-Fact acting on behalf of each of the Selling Stockholders named in Schedule 4 to this Agreement | ||||||
S-1
Accepted: [ ], 2007
d
X.X. XXXXXX SECURITIES INC.
BANC OF AMERICA SECURITIES LLC
BANC OF AMERICA SECURITIES LLC
For themselves and on behalf of the
several Underwriters listed
in Schedule 1 hereto.
several Underwriters listed
in Schedule 1 hereto.
X.X. XXXXXX SECURITIES INC.
By |
||||
BANC OF AMERICA SECURITIES LLC
By |
||||
S-1
Schedule 1
| Underwriter | Number of Shares | |
X.X. Xxxxxx Securities Inc. |
||
Banc of America Securities LLC |
||
Xxxxxx Brothers Inc. |
||
BNP Paribas Securities Corp. |
||
Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated |
||
UBS Securities LLC |
||
Wachovia Capital Markets, LLC |
||
| Total |
Sch 1-1
Schedule 2
Chase Stockholders:
|
Number of Underwritten Shares: | Number of Option Shares: | Percentage of Option Shares: | |||
Sch 2-1
Schedule 3
Chase Stockholder
|
Attorney-in-Fact | |
Chase Oil Corporation |
Caza Energy LLC |
Sch 4-1
Schedule 4
| Each Non-Chase Stockholder | Attorney-in-fact |
Sch 5-1
Annex A
[Opinion of Counsel for the Company]
A-1
Annex B
[Opinion of Counsel For
The Selling Stockholders]
The Selling Stockholders]
B-1
Annex C
a. Time of Sale Information
[list each Issuer Free Writing Prospectus to be included in the Time of Sale Information]1
[b. Pricing Information Provided Orally by Underwriters]
[set out key information included in script that will be used by underwriters to confirm
sales]
| 1 | Would generally include the filed IFWPs and any IFWP with preliminary terms of the Securities. |
C-1
Exhibit A
FORM OF LOCK-UP AGREEMENT
, 2007
X.X. XXXXXX SECURITIES INC.
BANK OF AMERICA SECURITIES LLC
As Representatives of
the several Underwriters listed in
Schedule I to the Underwriting
Agreement referred to below
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
BANK OF AMERICA SECURITIES LLC
As Representatives of
the several Underwriters listed in
Schedule I to the Underwriting
Agreement referred to below
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
Re: Concho Resources Inc. — Public Offering
Ladies and Gentlemen:
The undersigned understands that you, as Representatives of the several Underwriters, propose
to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Concho Resources Inc.,
a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”)
by the several Underwriters to be named in Schedule I to the Underwriting Agreement (the
“Underwriters”) of common stock of the Company (the “Securities”).
In consideration of the Underwriters’ agreement to purchase and make the Public Offering of
the Securities, and for other good and valuable consideration receipt of which is hereby
acknowledged, the undersigned hereby agrees that, without the prior written consent of X.X. Xxxxxx
Securities Inc. and Bank of America Securities LLC, on behalf of the Underwriters, the undersigned
will not, during the period ending 180 days after the date of the prospectus relating to the Public
Offering (the “Prospectus”), (1) offer, pledge, announce the intention to sell, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly,
any shares of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”) or any
securities convertible into or exercisable or exchangeable for Common Stock (including, without
limitation, Common Stock which may be deemed to be beneficially owned by the undersigned in
accordance with the rules and regulations of the Securities and Exchange Commission and securities
which may be issued upon exercise of a stock option or warrant) or (2) enter into any swap or other
agreement that transfers, in whole or in part, any of the economic consequences of ownership of the
Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by
delivery of Common Stock or such other securities, in cash or otherwise or (iii) make any demand
for or exercise any right with respect to the registration of any shares of Stock or any security
convertible into or exercisable or exchangeable for Stock without the prior written consent of the
Representatives, in each case other than (A) the Shares to be sold by such Selling Stockholder
hereunder, (B) transfers of shares of Stock as a bona fide gift or gifts, including to the Chase
Foundation, (C) transfers of shares of Stock or other securities to directors, officers or
employees of Chase Oil Corporation or its subsidiaries or affiliates and (D) distributions of
shares of Stock to members or stockholders of such Selling Stockholder; provided that in the case
of any transfer or distribution pursuant to clause (B), (C), or (D) each donee, transferee or
distributee shall execute and deliver to the Representatives a lock-up letter in the form of this
paragraph and provided, further, that in the case of any transfer or distribution pursuant to
clause (B) or (D) no filing by any party (donor, donee, transferor or transferee) under Section
16(a) of the Securities Exchange Act of 1934, as amended, shall be required or shall be made voluntarily in
Ex A-1
connection with such transfer or distribution (other than a
filing on a Form 5 made after the expiration of the 180-day period referred to above). In addition,
the undersigned agrees that, without the prior written consent of X.X. Xxxxxx Securities Inc. and
Bank of America Securities LLC on behalf of the Underwriters, it will not, during the period ending
180 days after the date of the Prospectus, make any demand for, or exercise any right with respect
to, the registration of any shares of Common Stock or any security convertible into or exercisable
or exchangeable for Common Stock.
Notwithstanding the foregoing, if (1) during the last 17 days of the 180-day restricted
period, the Company issues an earnings release or material news or a material event relating to the
Company occurs; or (2) prior to the expiration of the 180-day restricted period, the Company
announces that it will release earnings results during the 16-day period beginning on the last day
of the 180-day period, the restrictions imposed by this Letter Agreement shall continue to apply
until the expiration of the 18-day period beginning on the issuance of the earnings release or the
occurrence of the material news or material event; provided, however, that in no event shall such
restrictions extend past 214 days from the date of the Prospectus.
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to
make any transfer of securities if such transfer would constitute a violation or breach of this
Letter Agreement.
The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Letter Agreement. All authority herein conferred or agreed to be
conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.
The undersigned understands that, if the Underwriting Agreement does not become effective, or
if the Underwriting Agreement (other than the provisions thereof which survive termination) shall
terminate or be terminated prior to payment for and delivery of the Common Stock to be sold
thereunder, the undersigned shall be released form all obligations under this Letter Agreement.
The undersigned understands that to the extent the Underwriters enter into the Underwriting
Agreement and proceed with the Public Offering, they will be doing so in reliance upon this Letter
Agreement.
This Letter Agreement shall be governed by and construed in accordance with the laws of the
State of New York, without regard to the conflict of laws principles thereof.
| Very truly yours, | ||||||
| By: | ||||||
| Name: | ||||||
| Title: | ||||||
Ex A-2
